COMPOUNDS, COMPOSITIONS AND METHODS

The present disclosure relates generally to eukaryotic initiation factor 2B modulators, or a pharmaceutically acceptable salt, stereoisomer, mixture of stereoisomers, or prodrug thereof, and methods of making and using thereof.

Saved in:
Bibliographic Details
Main Authors SWEENEY, Zachary K, FENG, Jianwen A, ESTRADA, Anthony A, CRAIG, Robert A., II, DE VICENTE FIDALGO, Javier, OSIPOV, Maksim, LEXA, Katrina W
Format Patent
LanguageEnglish
French
German
Published 27.09.2023
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present disclosure relates generally to eukaryotic initiation factor 2B modulators, or a pharmaceutically acceptable salt, stereoisomer, mixture of stereoisomers, or prodrug thereof, and methods of making and using thereof.
Bibliography:Application Number: EP20230173466